AP217A - Injectable parasiticidal composition - Google Patents
Injectable parasiticidal composition Download PDFInfo
- Publication number
- AP217A AP217A APAP/P/1990/000216A AP9000216A AP217A AP 217 A AP217 A AP 217A AP 9000216 A AP9000216 A AP 9000216A AP 217 A AP217 A AP 217A
- Authority
- AP
- ARIPO
- Prior art keywords
- hydrogen
- substituted
- halogen
- composition according
- mixture
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/17—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Tropical Medicine & Parasitology (AREA)
- Dermatology (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Pyridine Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH389889 | 1989-10-27 |
Publications (2)
Publication Number | Publication Date |
---|---|
AP9000216A0 AP9000216A0 (en) | 1990-10-31 |
AP217A true AP217A (en) | 1992-09-10 |
Family
ID=4265876
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
APAP/P/1990/000216A AP217A (en) | 1989-10-27 | 1990-10-26 | Injectable parasiticidal composition |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP0425443A1 (de) |
JP (1) | JPH03161438A (de) |
KR (1) | KR910007521A (de) |
AP (1) | AP217A (de) |
AU (1) | AU632862B2 (de) |
CA (1) | CA2028536A1 (de) |
IE (1) | IE903877A1 (de) |
ZA (1) | ZA908597B (de) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU631259B2 (en) * | 1989-12-18 | 1992-11-19 | Ciba-Geigy Ag | Formulations of benzoylphenyl ureas for combating ectoparasites |
US5290794A (en) * | 1992-10-27 | 1994-03-01 | Warner Lambert Co. | Soluble calcium lactate antibacterial complexes as non-irritating parenteral forms |
IT1290845B1 (it) * | 1996-12-12 | 1998-12-14 | Isagro Spa | Composizioni per il controllo sistemico di parassiti di animali a sangue caldo |
TW480153B (en) * | 1997-11-20 | 2002-03-21 | Sumitomo Chemical Co | Method to control animal ecto-parasites |
US6239112B1 (en) * | 1998-07-09 | 2001-05-29 | Merial, Inc. | Water miscible macrolide solutions |
US8124630B2 (en) | 1999-01-13 | 2012-02-28 | Bayer Healthcare Llc | ω-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors |
EP2298311B1 (de) | 1999-01-13 | 2012-05-09 | Bayer HealthCare LLC | Omega-carboxyarylsubstituierte-Diphenyl-Harnstoffe als p38-Kinasehemmer |
WO2003068228A1 (en) | 2002-02-11 | 2003-08-21 | Bayer Pharmaceuticals Corporation | Aryl ureas with angiogenesis inhibiting activity |
AU2003209119A1 (en) | 2002-02-11 | 2003-09-04 | Bayer Pharmaceuticals Corporation | Pyridine, quinoline, and isoquinoline n-oxides as kinase inhibitors |
DK1580188T3 (da) | 2002-02-11 | 2012-02-06 | Bayer Healthcare Llc | Forbindelser af arylurea som kinaseinhibitorer |
UY28213A1 (es) | 2003-02-28 | 2004-09-30 | Bayer Pharmaceuticals Corp | Nuevos derivados de cianopiridina útiles en el tratamiento de cáncer y otros trastornos. |
EP1636585B2 (de) | 2003-05-20 | 2012-06-13 | Bayer HealthCare LLC | Diaryl-harnstoffe mit kinasehemmender wirkung |
ME00294B (me) | 2003-07-23 | 2011-05-10 | Bayer Pharmaceuticals Corp | Fluoro supstituisana omega-karaboksiaril difenil urea za liječenje i prevenciju bolesti i stanja bolesti |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4405644A (en) * | 1979-07-14 | 1983-09-20 | Bayer Aktiengesellschaft | Medicaments for the treatment of disorders of lipometabolism and their use |
EP0093977A1 (de) * | 1982-05-11 | 1983-11-16 | Bayer Ag | 2,5-Dihalogenbenzoyl-(thio)harnstoffe, Verfahren zu ihrer Herstellung und ihre Verwendung als Schädlingsbekämpfungsmittel |
EP0093976A1 (de) * | 1982-05-11 | 1983-11-16 | Bayer Ag | 2,4-Dihalogenbenzoyl-(thio)harnstoffe, Verfahren zu ihrer Herstellung und ihre Verwendung als Schädlingsbekämpfungsmittel |
EP0142667A1 (de) * | 1983-09-22 | 1985-05-29 | BASF Aktiengesellschaft | N-Benzoyl-N'-alkoxyphenylharnstoffe und ihre Verwendung zur Bekämpfung von Insekten und Akariden |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2051998T3 (es) * | 1988-02-29 | 1994-07-01 | Pfizer | Composiciones aumentadoras del flujo transdermal. |
-
1990
- 1990-10-19 EP EP90810805A patent/EP0425443A1/de not_active Ceased
- 1990-10-25 CA CA002028536A patent/CA2028536A1/en not_active Abandoned
- 1990-10-25 AU AU64998/90A patent/AU632862B2/en not_active Expired - Fee Related
- 1990-10-26 IE IE387790A patent/IE903877A1/en unknown
- 1990-10-26 AP APAP/P/1990/000216A patent/AP217A/en active
- 1990-10-26 ZA ZA908597A patent/ZA908597B/xx unknown
- 1990-10-26 JP JP2287423A patent/JPH03161438A/ja active Pending
- 1990-10-27 KR KR1019900017269A patent/KR910007521A/ko not_active Application Discontinuation
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4405644A (en) * | 1979-07-14 | 1983-09-20 | Bayer Aktiengesellschaft | Medicaments for the treatment of disorders of lipometabolism and their use |
EP0093977A1 (de) * | 1982-05-11 | 1983-11-16 | Bayer Ag | 2,5-Dihalogenbenzoyl-(thio)harnstoffe, Verfahren zu ihrer Herstellung und ihre Verwendung als Schädlingsbekämpfungsmittel |
EP0093976A1 (de) * | 1982-05-11 | 1983-11-16 | Bayer Ag | 2,4-Dihalogenbenzoyl-(thio)harnstoffe, Verfahren zu ihrer Herstellung und ihre Verwendung als Schädlingsbekämpfungsmittel |
EP0142667A1 (de) * | 1983-09-22 | 1985-05-29 | BASF Aktiengesellschaft | N-Benzoyl-N'-alkoxyphenylharnstoffe und ihre Verwendung zur Bekämpfung von Insekten und Akariden |
Also Published As
Publication number | Publication date |
---|---|
AU632862B2 (en) | 1993-01-14 |
AP9000216A0 (en) | 1990-10-31 |
KR910007521A (ko) | 1991-05-30 |
IE903877A1 (en) | 1991-05-08 |
CA2028536A1 (en) | 1991-04-28 |
JPH03161438A (ja) | 1991-07-11 |
EP0425443A1 (de) | 1991-05-02 |
ZA908597B (en) | 1991-07-31 |
AU6499890A (en) | 1991-05-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AP217A (en) | Injectable parasiticidal composition | |
US5177110A (en) | Injectable parasiticidal composition | |
EP0546018B1 (de) | Florfenicol enthaltendes arzneimittel | |
EP1610613B1 (de) | Topische anthelmintika-formulierungen für den veterinärbereich | |
CN106474120B (zh) | 包含异噁唑啉活性剂的杀寄生物组合物,其方法和用途 | |
EP1713466B1 (de) | Antiparasitische zusammensetzung mit einem organischen aminsalz von closantel | |
EP0137627B1 (de) | Aufgiessformulierung gegen Parasiten | |
EP1551390B1 (de) | Formulierung enthaltend Avermectine / Milbemycine und Levamisol in einem Pyrrolidon-Lösungsmittel | |
NZ248486A (en) | Stable anthelmintic formulation containing closantel and one or more avermectins or milbemycins in a glycol based solvent | |
KR101526285B1 (ko) | 동물의 기생충 구제용 약제 | |
JPH05246893A (ja) | 水素化ひまし油を含む長期持続性注射製剤 | |
KR20080073700A (ko) | 벤즈이미다졸 비수성 조성물 | |
US7094414B2 (en) | Famotidine injections | |
CN1822880B (zh) | 杀灭寄生物的组合物 | |
EP0136033A2 (de) | Aufgiessformulierung gegen Parasiten | |
EP0433909A2 (de) | Formulierung | |
AU2005336458B2 (en) | Anthelmintic formulations | |
JPS6242924A (ja) | 駆虫剤および殺菌剤組成物 | |
CA2839491A1 (en) | Anti-parasitic composition comprising a macrocyclic lactone and levamisole and method of treatment of parasitic infestation | |
JPH11511479A (ja) | 1,2,4−ベンゾトリアジンオキシド製剤 | |
IE54131B1 (en) | Anthelmintic imidazo (2,1-b) thiazole salts | |
US11903962B1 (en) | Isoxazoline complexes and compositions thereof | |
JP7523439B2 (ja) | 活性医薬成分の安定性向上のための製剤、方法、kit、及び剤形 | |
AU2002100152B4 (en) | Parasiticide composition | |
RU2660353C2 (ru) | Способ и улучшенная фармацевтическая композиция для ускорения трансдермальной доставки ингибитора pde-5 |